INNL Innocoll Holdings

2.35
+0.00  (0%)
Previous Close 2.35
Open 2.25
Price To book 142.07
Market Cap 936760765
Shares 398,621,602
Volume 0
Short Ratio 15.61
Av. Daily Volume 87,692

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data did not meet endpoints - November 3, 2016.
Cogenzia
Diabetic foot ulcer infections
Refusal to file letter received December 29, 2016. Intends to initiate short-term Pharmacokinetic study and several short-term non-clinical studies before resubmitting NDA filing in late 2017.
XaraColl
Post-operative pain